DE2661002C2 - - Google Patents
Info
- Publication number
- DE2661002C2 DE2661002C2 DE2661002A DE2661002A DE2661002C2 DE 2661002 C2 DE2661002 C2 DE 2661002C2 DE 2661002 A DE2661002 A DE 2661002A DE 2661002 A DE2661002 A DE 2661002A DE 2661002 C2 DE2661002 C2 DE 2661002C2
- Authority
- DE
- Germany
- Prior art keywords
- ethynyl
- ethyl
- rats
- acetoxy
- oxime
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Description
Claims (1)
- Kontrazeptives Mittel auf der Grundlage wirksamer Mengen gestagener Steroide des 17α-Äthinyl-17β-acyloxy-13β-alkyl- 19-nortestosteron-3-oxim-Typs, dadurch gekennzeichnet, daß es aus D-17α-Äthinyl-17β-acetoxy-13β-äthyl- gon-4-en-3-oxim sowie einer östrogenen Komponente aus der Gruppe 17a-Äthinylöstradiol, 17β-Östradiol, 17α-Äthinyl- 17β-hydroxy-3-methoxy-1,3,5-östratrien ("Mestranol") oder 17α-Äthinyl-östradiol-3-cyclopentyläther und üblichen pharmazeutischen Hilfsstoffen besteht.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59896675A | 1975-07-24 | 1975-07-24 | |
US05/652,000 US4027019A (en) | 1975-07-24 | 1976-01-23 | 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2661002A1 DE2661002A1 (de) | 1985-05-02 |
DE2661002C2 true DE2661002C2 (de) | 1988-03-17 |
Family
ID=27083202
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19762633210 Granted DE2633210A1 (de) | 1975-07-24 | 1976-07-23 | D-17 alpha-aethinyl-17 beta-acyloxy- 19-nortestosteron-3-oxime, verfahren zu ihrer herstellung und diese verbindungen enthaltende fertilitaetshemmende mittel |
DE2661002A Expired DE2661002C2 (de) | 1975-07-24 | 1976-07-23 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19762633210 Granted DE2633210A1 (de) | 1975-07-24 | 1976-07-23 | D-17 alpha-aethinyl-17 beta-acyloxy- 19-nortestosteron-3-oxime, verfahren zu ihrer herstellung und diese verbindungen enthaltende fertilitaetshemmende mittel |
Country Status (22)
Country | Link |
---|---|
US (1) | US4027019A (de) |
JP (1) | JPS5214760A (de) |
AT (1) | AT350748B (de) |
AU (1) | AU501808B2 (de) |
CA (1) | CA1072948A (de) |
CH (1) | CH599249A5 (de) |
DE (2) | DE2633210A1 (de) |
DK (1) | DK145610C (de) |
ES (1) | ES450108A1 (de) |
FI (1) | FI55036C (de) |
FR (1) | FR2318645A1 (de) |
GB (1) | GB1557197A (de) |
IE (1) | IE43581B1 (de) |
IL (1) | IL50103A (de) |
MX (1) | MX3417E (de) |
NL (1) | NL192206C (de) |
NO (1) | NO143350C (de) |
NZ (1) | NZ181130A (de) |
PH (1) | PH12003A (de) |
PT (1) | PT65402B (de) |
SE (2) | SE421800B (de) |
YU (1) | YU39968B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4507290A (en) * | 1981-04-07 | 1985-03-26 | World Health Organization | Esters of 17 α-ethynyl 19-nor-testosterone and 17 α-ethynyl-18-homo-19-nor-testosterone and pharmaceutical compositions containing the same |
GB8313921D0 (en) * | 1983-05-19 | 1983-06-22 | World Health Org | Contraceptive compositions |
AU3257993A (en) * | 1991-12-22 | 1993-07-28 | Schering Aktiengesellschaft | 3-methylsulphonylhydrazono and 3-oxyimino steroids, a method of preparing them, pharmaceutical preparations containing them and their use in the preparation of drugs |
US7989436B2 (en) * | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
US7459445B2 (en) * | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
US6660726B2 (en) | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
CA2435350A1 (en) * | 2001-02-02 | 2002-08-15 | Pharmacia Corporation | Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea |
US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
CA2521471A1 (en) * | 2003-04-11 | 2004-10-28 | Barr Laboratories, Inc. | Methods of administering estrogens and progestins |
AR039733A1 (es) * | 2003-06-25 | 2005-03-09 | Gador Sa | Proceso para la obtencion de norelgestromin en distintas relaciones de los isomeros e y z |
HUP0301982A2 (hu) * | 2003-06-30 | 2005-04-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás nagy tisztaságú d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-oxim előállítására |
US7576226B2 (en) * | 2003-06-30 | 2009-08-18 | Richter Gedeon Vegyeszeti Gyar Rt. | Process of making isomers of norelgestromin and methods using the same |
HUP0301981A2 (hu) * | 2003-06-30 | 2005-04-28 | Richter Gedeon Vegyészeti Gyár Rt. | Tiszta d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-3E- és 3Z-oxim izomerek, valamint eljárás az izomer keverékek és a tiszta izomerek előállítására |
KR20070049153A (ko) * | 2004-08-12 | 2007-05-10 | 시코르, 인크. | 3-옥시미노 스테로이드의 제조 방법 |
WO2006084082A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1493161B2 (de) | 1951-01-28 | 1973-08-30 | 17alpha-aethinyl-18-methyl-19nortestosteronester, verfahren zu ihrer herstellung und diese enthaltendes mittel | |
US3780073A (en) * | 1966-07-06 | 1973-12-18 | Ortho Pharma Corp | 3-oximes of 19-nortestosterone esters |
US3532689A (en) * | 1967-04-20 | 1970-10-06 | Ortho Pharma Corp | 3-oxime and 3-oxime esters of 19-nortestosterone |
NL7306609A (de) * | 1972-05-26 | 1973-11-28 | ||
US3912768A (en) * | 1972-09-26 | 1975-10-14 | Warner Lambert Co | Norethindrone O-alkyloximes |
-
1976
- 1976-01-23 US US05/652,000 patent/US4027019A/en not_active Expired - Lifetime
- 1976-06-11 NZ NZ181130A patent/NZ181130A/en unknown
- 1976-06-14 FR FR7617973A patent/FR2318645A1/fr active Granted
- 1976-06-14 PH PH18572A patent/PH12003A/en unknown
- 1976-06-15 GB GB24769/76A patent/GB1557197A/en not_active Expired
- 1976-06-28 AU AU15357/76A patent/AU501808B2/en not_active Expired
- 1976-07-06 CA CA256,343A patent/CA1072948A/en not_active Expired
- 1976-07-13 YU YU1733/76A patent/YU39968B/xx unknown
- 1976-07-22 IL IL50103A patent/IL50103A/xx unknown
- 1976-07-22 MX MX001792U patent/MX3417E/es unknown
- 1976-07-22 CH CH940376A patent/CH599249A5/xx not_active IP Right Cessation
- 1976-07-22 JP JP51086661A patent/JPS5214760A/ja active Granted
- 1976-07-23 NL NL7608210A patent/NL192206C/nl not_active IP Right Cessation
- 1976-07-23 IE IE1636/76A patent/IE43581B1/en unknown
- 1976-07-23 PT PT65402A patent/PT65402B/pt unknown
- 1976-07-23 DE DE19762633210 patent/DE2633210A1/de active Granted
- 1976-07-23 DK DK335876A patent/DK145610C/da not_active IP Right Cessation
- 1976-07-23 DE DE2661002A patent/DE2661002C2/de not_active Expired
- 1976-07-23 FI FI762116A patent/FI55036C/fi not_active IP Right Cessation
- 1976-07-23 SE SE7608407A patent/SE421800B/xx not_active IP Right Cessation
- 1976-07-23 AT AT543976A patent/AT350748B/de not_active IP Right Cessation
- 1976-07-23 NO NO762583A patent/NO143350C/no unknown
- 1976-07-23 ES ES450108A patent/ES450108A1/es not_active Expired
-
1979
- 1979-12-14 SE SE7910336A patent/SE445458B/sv not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2661002C2 (de) | ||
EP0770388B1 (de) | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene | |
DE2310963A1 (de) | Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten | |
EP0787002B1 (de) | Kompetitive progesteronantagonisten zur bedarfsorientierten weiblichen fertilitätskontrolle | |
DE2818164A1 (de) | 1,3-dibenzoesaeureester des 17alpha- ethinyl-7 alpha -methyl-1,3,5(10)-oestratrien- 1,3,17 beta -triols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE1618980B2 (de) | In 17-stellung substituierte 11, 13beta-dialkylgon-4-en-3,17beta-diole und deren ester | |
DE2147391A1 (de) | 13-Polycarbonalkyl-16-methylgonal,3,5(10>triene und B-Polycarbonalkyl-lomethylgon-4-en-3-one und Zwischenprodukte sowie Verfahren zu ihrer Herstellung | |
DE3628189A1 (de) | Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene | |
DE1298993B (de) | 3-Oxo-8ª‡-17ª‰-hydroxy-17ª‡-aethinyl-oestr-5(10)-en in seiner racemischen und linksdrehenden Form und Verfahren zur Herstellung dieser Verbindungen | |
DE1617839A1 (de) | Methode zur Kontrazeption | |
DE2348197C3 (de) | Norethisteron-O-alkyloxime, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
EP0031591A1 (de) | 2,2-Dimethyl-3-oxoandrosta-4,6-dien-17S-spiro-5'-(2'-oxo-3'-methyloxazolidin), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
DE2048231C3 (de) | Gestagenes oder zur Regulierung der Fertllität dienendes Mittel | |
DE2037155A1 (de) | ||
DE1593204C (de) | 19-nor-Delta hoch 4,6 -3,20-Diketosteroide, Verfahren zu ihrer Herstellung und Arzneimittel | |
EP0707593B1 (de) | Oral estrogen wirksame ester des 14 alpha,15 alpha-methylen-estradiols | |
DE1493161C3 (de) | ||
DE1643046C3 (de) | OehydroepiarKSrosteron-3-önanthat, dieses enthaltende Arzneimittel sowie Verfahren zu seiner Herstellung | |
DE2433406C3 (de) | ||
DE1793677C3 (de) | Verfahren zur Herstellung von 8-Hydroxygona-13r5(10)-trienen und 8-Hydroxygona-13,5(10),9(ll)-tetraenen und gewisse neue 8-Hydroxygona-133(10)-triene und 8-Hydroxygona-13Ä10),9(l l)-tetraene | |
DE1902641C3 (de) | 3-Cyclopentyloxysteroide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE1493032C (de) | Verfahren zur Herstellung von 2 alpha. 3 alpha-Epithiosteroiden | |
DE2362813C3 (de) | Sbeta-Cycloalkyloxy-iealpha-cyan-pregn-Sen-20-one, Verfahren zu deren Herstellung sowie diese enthaltende Mittel Syntex (U.S.A.) Inc., Palo Alto, Calif. (V.St.A.) | |
AT251772B (de) | Verfahren zur Herstellung eines neuen Äthinylderivates des 8-iso-Östrons | |
AT231617B (de) | Verfahren zur Herstellung von 4-Hydroxy- bzw 4-Acyloxy-17α-methyl-19-nortestosteron |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
Q172 | Divided out of (supplement): |
Ref country code: DE Ref document number: 2633210 |
|
8110 | Request for examination paragraph 44 | ||
AC | Divided out of |
Ref country code: DE Ref document number: 2633210 Format of ref document f/p: P |
|
AC | Divided out of |
Ref country code: DE Ref document number: 2633210 Format of ref document f/p: P |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN |
|
8328 | Change in the person/name/address of the agent |
Free format text: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 81679 MUENCHEN VOSSIUS, C. VOSSIUS, T., RECHTSANWAELTE, 8000 MUENCHEN |